336 results on '"Katsuki, Asuka"'
Search Results
2. Pharmacological management of depression: Japanese expert consensus
3. Relationship between VEGF-related gene polymorphisms and brain morphology in treatment-naïve patients with first-episode major depressive disorder
4. An independent component analysis reveals brain structural networks related to TNF-α in drug-naïve, first-episode major depressive disorder: a source-based morphometric study
5. Brain structural network alterations related to serum cortisol levels in drug-naïve, first-episode major depressive disorder patients: a source-based morphometric study
6. Plasma levels of 3-methoxy-4-hydroxyphenylglycol levels, number of hospitalization and cognitive function predicts the cognitive effect of atypical antipsychotic monotherapy in patients with acute schizophrenia
7. Validity and Responsiveness of the Work Functioning Impairment Scale in Workers With Depression
8. Cognitive insight and functional outcome in schizophrenia; a multi-center collaborative study with the specific level of functioning scale–Japanese version
9. Decreased Activity at the Time of Return to Work Predicts Repeated Sick Leave in Depressed Japanese Patients
10. Brain structural connectivity and neuroticism in healthy adults
11. Relationship between the catechol-O-methyl transferase Val108/158Met genotype and brain volume in treatment-naive major depressive disorder: Voxel-based morphometry analysis
12. Relationship between a BDNF gene polymorphism and the brain volume in treatment-naive patients with major depressive disorder: A VBM analysis of brain MRI
13. Relationship between white matter integrity and serum inflammatory cytokine levels in drug-naive patients with major depressive disorder: diffusion tensor imaging study using tract-based spatial statistics
14. Relationship between interleukin (IL)-6 and brain morphology in drug-naïve, first-episode major depressive disorder using surface-based morphometry
15. Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients
16. Current smoking rate in patients with psychiatric disorders in Japan: Questionnaire survey
17. Transdiagnostic comparisons of intellectual abilities and work outcome in patients with mental disorders: multicentre study
18. Relationship between white matter integrity and serum cortisol levels in drug-naive patients with major depressive disorder: diffusion tensor imaging study using tract-based spatial statistics
19. Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder
20. Plasma Levels of Metabolites of Catecholamine in Nicotine-Dependent Patients Treated With Varenicline
21. The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients
22. Pre-treatment plasma cytokine levels as potential predictors of short-term remission of depression
23. Pretreatment plasma cytokine levels as potential predictors of short-term remission of depression
24. Relationships between stress, social adaptation, personality traits, brain-derived neurotrophic factor and 3-methoxy-4-hydroxyphenylglycol plasma concentrations in employees at a publishing company in Japan
25. No alterations of brain GABA after 6 months of treatment with atypical antipsychotic drugs in early-stage first-episode schizophrenia
26. RELATIONSHIP BETWEEN THE CORTICAL THICKNESS AND SERUM CORTISOL LEVELS IN DRUG-NAÏVE, FIRST-EPISODE PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A SURFACE-BASED MORPHOMETRIC STUDY
27. Predictors of return to work success among Japanese employees with major depressive disorder
28. The brain-derived neurotrophic factor Val66Met polymorphism increases segregation of structural correlation networks in healthy adult brains
29. The effect of duration of illness and antipsychotics on subcortical volumes in schizophrenia: Analysis of 778 subjects
30. Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus
31. Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder
32. Plasma catecholamine metabolite levels and the activities of psychiatric symptoms in systemic lupus erythematosus
33. Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients
34. Three polymorphisms of the eNOS gene and plasma levels of metabolites of nitric oxide in depressed Japanese patients: a preliminary report
35. No association between BDNF Val66Met polymorphism and emergence of psychiatric symptoms in systemic lupus erythematosus patients
36. Effects of the number of hospitalizations on cognitive function in Japanese patients with stable schizophrenia
37. The brain-derived neurotrophic factor Val66Met polymorphism increases segregation of structural correlation networks in healthy adult brains
38. Structural Changes in Hippocampal Subfields in Patients with Continuous Remission of Drug-Naive Major Depressive Disorder
39. A refractory case of a male patient with neuropsychiatric systemic lupus erythematosus with various psychiatric symptoms and MRI observations
40. Hippocampal Network Abnormality in Major Depressive Disorder [Presidential Award Proceedings]
41. Plasma levels of brain – derived neurotrophic factor and interleukin – 6 in patients with dysthymic disorder: comparison with age – and sex – matched major depressed patients and healthy controls
42. No difference in adherence to paroxetine between depressed patients with early remission and those with late remission based on monitoring of plasma paroxetine concentrations
43. Varenicline does not increase serum BDNF levels in patients with nicotine dependence
44. Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression
45. A single-nucleotide polymorphism influences brain morphology in drug-naïve patients with major depressive disorder
46. COMT polymorphism regulates the hippocampal subfield volumes in first-episode, drug-naive patients with major depressive disorder
47. Social cognition and metacognition contribute to accuracy for self-evaluation of real-world functioning in patients with schizophrenia
48. Brain structural connectivity and neuroticism in healthy adults
49. Genetic effects on white matter integrity in drug-naive patients with major depressive disorder: a diffusion tensor imaging study of 17 genetic loci associated with depressive symptoms
50. Risk factors for further sick leave among Japanese workers returning to work after an episode of major depressive disorder: a prospective follow-up study over 1 year
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.